• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SS Innovations International Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    1/8/26 5:05:54 PM ET
    $SSII
    Medical/Dental Instruments
    Health Care
    Get the next $SSII alert in real time by email
    false 0001676163 0001676163 2026-01-02 2026-01-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    FORM 8-K

     

    Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

     

    Date of report (Date of earliest event reported): January 2, 2026

     

    SS INNOVATIONS INTERNATIONAL, INC.

    (Exact name of registrant as specified in its charter)

     

    Florida   001-42615   47-3478854
    (State or Other Jurisdiction
    of Incorporation)
      (Commission File Number)   (IRS Employer
    Identification No.)

     

    405, 3rd Floor, iLabs Info Technology Centre
    Udyog Vihar, Phase III

    Gurugram
    , Haryana India

      122016
    (Address of Principal Executive Offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: +91 73375 53469

     

     

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each Class   Trading Symbol   Name of each exchange on which registered
    Common Stock   SSII   The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    As used in this Current Report on Form 8-K (this ”Current Report”), the terms “SSi,” “the Company,” “we,” “us” and “our” refer to SS Innovations International, Inc. and its subsidiaries.

     

    Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

     

    Resignation of Former Chief Financial Officer

     

    On January 2, 2026, Naveen Kumar Amar resigned as our Chief Financial Officer for personal reasons.

     

    Appointment of Global Chief Operating Officer and new Chief Financial Officer

     

    On January 8, 2026, we issued a press release announcing that on January 6, 2026, SSi’s board of directors appointed Milan Rao to the newly created position of Global Chief Operating Officer and as the Company’s new Chief Financial Officer, effective January 16, 2026. Mr. Rao will be based in Princeton, New Jersey. A copy of the press release is attached as Exhibit 99.1 to this Current Report and is incorporated herein by reference.

     

    Mr. Rao, age 54, has more than three decades of executive leadership experience driving technology-enabled transformation, operational efficiency and growth at leading global companies across industries, including the healthcare sector. From June 2024 until joining the Company, Mr. Rao has been serving as Chief Operating Officer and Chief Revenue Officer of Markets & Markets, a global consulting firm based in New York City, where he led global operations, sales, marketing and consulting, and was responsible for global partnerships and the firm’s inorganic growth initiatives. From September 2021 to December 2023, Mr. Rao served as President and Global Business Head of Smart Energy Water (“SEW”), a cloud-based SaaS company based in California and New York, connecting consumers with energy and water providers worldwide. He led global scaling across more than 35 countries to 400 customers and 1.1 billion subscribers, overseeing sales, customer success, presales, solution engineering, marketing, product delivery, and operations. Following SEW’s acquisition of Choice Technologies, in 2022 he served as Interim Chief Executive Officer of Choice Technologies and led its global integration with SEW, expanding platform capabilities in artificial intelligence, machine learning and data analytics and growing its customer base. From August 2017 to August 2021, Mr. Rao was President at Wipro Limited (“Wipro”) a Technology Services company. Based in Princeton, New Jersey, he managed business units having revenues of approximately $1.8 billion with a workforce exceeding 25,000 and led turnarounds of the Industrials & Automotive and Telecommunications strategic business units. He also led Wipro’s Technology & Transformation Office, including innovation, IP and platforms, marketing, and revenue operations, and launched a digital-first, AI-led transformation program. From June 2013 to August 2017, Mr. Rao served as President and Chief Executive Officer of GE Healthcare for India, South Asia, and emerging markets, managing an approximately $800 million business with 5,000 employees across multiple entities. He advanced GE’s India strategy as a center for research and development, technology, and manufacturing, supporting roughly 2,000 scientists and engineers and more than 2,000 manufacturing and service personnel across three plants, which contributed to over 20 value products for global markets and a threefold increase in local manufacturing and exports. Mr. Rao holds a BS in Computer Science and Engineering from IIT (BHU) Varanasi, where he was recognized as a Distinguished Alumnus, and an MBA in Finance from IIM Calcutta.

     

    The Company and Mr. Rao entered into a one-year services agreement, effective January 16, 2026 (the “Services Agreement”), providing for monthly base compensation of $41,667. In addition, the Services Agreement provides for Mr. Rao to receive a stock grant under the Company’s 2016 Incentive Stock Plan (the “Incentive Plan”) in the amount of 120,000 shares of the Company’s common stock vesting in equal monthly installments of 10,000 shares, subject to continued engagement of Mr. Rao by the Company and the other terms and conditions of the Incentive Plan. The Services Agreement contains customary confidentiality, assignment of proprietary rights, non-competition and non-solicitation provisions.

     

    The above summary of the Services Agreement is qualified in its entirety by reference to the Services Agreement, a copy of which is attached as Exhibit 10.1 to this Current Report and is incorporated herein by reference.

     

    1

     

     

    Item 9.01 Financial Statements and Exhibits.

     

    (d) Exhibits

     

    Exhibit No.   Description
    10.1   Services Agreement between SS Innovations International, Inc. and Milan Rao
    99.1   Press Release, dated January 8, 2026
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

    2

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Dated: January 8, 2026 SS INNOVATIONS INTERNATIONAL, INC.
         
      By:  /s/ Sudhir Srivastava
        Sudhir Srivastava, M.D.
        Chairman and Chief Executive Officer

     

    3

    Get the next $SSII alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SSII

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SSII
    SEC Filings

    View All

    SEC Form D filed by SS Innovations International Inc.

    D - SS Innovations International, Inc. (0001676163) (Filer)

    3/19/26 4:05:20 PM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    SS Innovations International Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - SS Innovations International, Inc. (0001676163) (Filer)

    3/18/26 8:35:07 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    SS Innovations International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - SS Innovations International, Inc. (0001676163) (Filer)

    3/10/26 8:30:29 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    $SSII
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Adams Timothy P. bought $1,197,000 worth of shares (300,000 units at $3.99) (SEC Form 4)

    4 - SS Innovations International, Inc. (0001676163) (Issuer)

    3/10/26 6:04:41 PM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    Director Moll Frederic H bought $1,999,999 worth of shares (501,253 units at $3.99), increasing direct ownership by 5% to 10,775,485 units (SEC Form 4)

    4 - SS Innovations International, Inc. (0001676163) (Issuer)

    3/10/26 6:05:34 PM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    Amendment: COO - Americas Cohen Barry F bought $3,799 worth of shares (426 units at $8.92), increasing direct ownership by 0.00% to 8,866,888 units (SEC Form 4)

    4/A - SS Innovations International, Inc. (0001676163) (Issuer)

    6/30/25 6:55:24 PM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    $SSII
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Adams Timothy P. bought $1,197,000 worth of shares (300,000 units at $3.99) (SEC Form 4)

    4 - SS Innovations International, Inc. (0001676163) (Issuer)

    3/10/26 6:04:41 PM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by SS Innovations International Inc.

    4 - SS Innovations International, Inc. (0001676163) (Issuer)

    3/10/26 6:03:34 PM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    Director Moll Frederic H bought $1,999,999 worth of shares (501,253 units at $3.99), increasing direct ownership by 5% to 10,775,485 units (SEC Form 4)

    4 - SS Innovations International, Inc. (0001676163) (Issuer)

    3/10/26 6:05:34 PM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    $SSII
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SS Innovations' SSi Mantra Surgical Robotic System Approved for Telesurgeries in Indonesia and the Philippines

    FORT LAUDERDALE, Fla., March 18, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company's SSi Mantra surgical robotic system has been approved for telesurgeries in Indonesia and the Philippines. The Company today also announced that more than 150 cumulative telesurgeries have been successfully performed utilizing the SSi Mantra surgical robotic system, primarily in India. Among recent highlights showcasing the advanced capabilities of the SSi Mantra, a total of

    3/18/26 8:30:00 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    SS Innovations Reports Fourth Quarter and Full Year 2025 Financial Results

    FORT LAUDERDALE, Fla., March 10, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced unaudited financial results for the three and twelve months ended December 31, 2025. The Company also filed its Annual Report on Form 10-K for the year ended December 31, 2025, with the Securities and Exchange Commission on March 10, 2026. Fourth Quarter 2025 Overview Revenue increased 79.1% to $14.5 million from $8.1 million in the fourth quarter of 2024.Gross margin of 43.9% compared to 48

    3/10/26 8:30:00 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    SS Innovations Announces Completion of an $18.6 Million Private Placement to Support Growth Initiatives

    FORT LAUDERDALE, Fla., March 09, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that on March 6, 2026, the Company completed a private placement of its common stock (the "Private Placement") which generated approximately $18.6 million in gross proceeds, before deducting offering expenses. In the offering, the Company offered and sold a total of 5,774,839 shares of common stock consisting of: an aggregate of 1,300,006 shares of common stock at an average price of $4.00 p

    3/9/26 8:30:00 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    $SSII
    Leadership Updates

    Live Leadership Updates

    View All

    SS Innovations Appoints Milan Rao as Global Chief Operating Officer and Chief Financial Officer

    FORT LAUDERDALE, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the appointment of Milan Rao as the Company's Global Chief Operating Officer and Chief Financial Officer. The Global Chief Operating Officer role is a newly created position. Mr. Rao will succeed Naveen Kumar Amar as Chief Financial Officer following Mr. Amar's resignation from the Company for personal reasons. Mr. Rao will be based in the United States and will work closely with the Chairman a

    1/8/26 5:00:00 PM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    SS Innovations Appoints Naveen Kumar Amar as Chief Financial Officer

    FORT LAUDERDALE, Fla., Sept. 26, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the appointment of Naveen Kumar Amar as the Company's Chief Financial Officer, effective September 24, 2025. Mr. Amar is assuming the Chief Financial Officer role, on a permanent basis, from Dr. Vishwa Srivastava, who has served as the Company's Interim Chief Financial Officer since July 2025. Dr. Vishwa Srivastava will continue in his capacity as the Company's Chief Executive Officer – Asia

    9/26/25 8:30:00 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    SS Innovations Announces Chief Financial Officer Transition

    FORT LAUDERDALE, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the appointment of Arvind Palaniappan as the Company's Interim Chief Financial Officer, effective May 1, 2025, pursuant to a planned leadership transition. Anup Sethi, SS Innovations' departing CFO, will remain available to advise the Company prior to the appointment of a permanent CFO.   SS Innovations has commenced a search process to identify and recruit a permanent successor for the CFO role

    5/2/25 8:30:00 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care